Literature DB >> 20004762

Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome.

Munis Dündar1, Thomas Müller, Qi Zhang, Jing Pan, Beat Steinmann, Julia Vodopiutz, Robert Gruber, Tohru Sonoda, Birgit Krabichler, Gerd Utermann, Jacques U Baenziger, Lijuan Zhang, Andreas R Janecke.   

Abstract

Adducted thumb-clubfoot syndrome is an autosomal-recessive disorder characterized by typical facial appearance, wasted build, thin and translucent skin, congenital contractures of thumbs and feet, joint instability, facial clefting, and coagulopathy, as well as heart, kidney, or intestinal defects. We elucidated the molecular basis of the disease by using a SNP array-based genome-wide linkage approach that identified distinct homozygous nonsense and missense mutations in CHST14 in each of four consanguineous families with this disease. The CHST14 gene encodes N-acetylgalactosamine 4-O-sulfotransferase 1 (D4ST1), which catalyzes 4-O sulfation of N-acetylgalactosamine in the repeating iduronic acid-alpha1,3-N-acetylgalactosamine disaccharide sequence to form dermatan sulfate. Mass spectrometry of glycosaminoglycans from a patient's fibroblasts revealed absence of dermatan sulfate and excess of chondroitin sulfate, showing that 4-O sulfation by CHST14 is essential for dermatan sulfate formation in vivo. Our results indicate that adducted thumb-clubfoot syndrome is a disorder resulting from a defect specific to dermatan sulfate biosynthesis and emphasize roles for dermatan sulfate in human development and extracellular-matrix maintenance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004762      PMCID: PMC2790573          DOI: 10.1016/j.ajhg.2009.11.010

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  46 in total

1.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 2.  Heparan sulphate proteoglycans: the sweet side of development.

Authors:  Udo Häcker; Kent Nybakken; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

3.  Defective protein glycosylation in patients with cutis laxa syndrome.

Authors:  Eva Morava; Suzan Wopereis; Paul Coucke; Gabrielle Gillessen-Kaesbach; Thomas Voit; Jan Smeitink; Ron Wevers; Stephanie Grünewald
Journal:  Eur J Hum Genet       Date:  2005-04       Impact factor: 4.246

Review 4.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

5.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice.

Authors:  T Xu; P Bianco; L W Fisher; G Longenecker; E Smith; S Goldstein; J Bonadio; A Boskey; A M Heegaard; B Sommer; K Satomura; P Dominguez; C Zhao; A B Kulkarni; P G Robey; M F Young
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

6.  Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.

Authors:  G H Burch; Y Gong; W Liu; R W Dettman; C J Curry; L Smith; W L Miller; J Bristow
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity.

Authors:  Kristen R Taylor; Jennifer A Rudisill; Richard L Gallo
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

8.  Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Authors:  K G Danielson; H Baribault; D F Holmes; H Graham; K E Kadler; R V Iozzo
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

9.  Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis.

Authors:  Michael Klüppel; Thomas N Wight; Christina Chan; Aleksander Hinek; Jeffrey L Wrana
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

10.  Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.

Authors:  Cristina P Vicente; Li He; Mauro S G Pavão; Douglas M Tollefsen
Journal:  Blood       Date:  2004-08-17       Impact factor: 22.113

View more
  47 in total

1.  Myopathy in a 20-year-old female patient with D4ST-1 deficient Ehlers-Danlos syndrome due to a homozygous CHST14 mutation.

Authors:  N C Voermans; M Kempers; M Lammens; N van Alfen; M C Janssen; C Bönnemann; B G van Engelen; B C Hamel
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

Review 2.  Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.

Authors:  Kenneth L Kramer
Journal:  Semin Cell Dev Biol       Date:  2010-07-03       Impact factor: 7.727

3.  The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Authors:  Andreas R Janecke; Ben Li; Manfred Boehm; Birgit Krabichler; Marianne Rohrbach; Thomas Müller; Irene Fuchs; Gretchen Golas; Yasuhiro Katagiri; Shira G Ziegler; William A Gahl; Yael Wilnai; Nicoletta Zoppi; Herbert M Geller; Cecilia Giunta; Anne Slavotinek; Beat Steinmann
Journal:  Am J Med Genet A       Date:  2015-09-16       Impact factor: 2.802

Review 4.  Extracellular Matrix and Regenerative Therapies from the Cardiac Perspective.

Authors:  Arin Dogan; Mahmut Parmaksız; A Eser Elçin; Y Murat Elçin
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

5.  Mutational analysis of 12 patients with the phenotype of Ehlers-Danlos syndrome type VIB shows no linkage to the zinc transporter gene SLC39A13.

Authors:  Linda C Walker; Elizabeth M Ju; Heather N Yeowell
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

6.  Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.

Authors:  Matthias Baumann; Cecilia Giunta; Birgit Krabichler; Franz Rüschendorf; Nicoletta Zoppi; Marina Colombi; Reginald E Bittner; Susana Quijano-Roy; Francesco Muntoni; Sebahattin Cirak; Gudrun Schreiber; Yaqun Zou; Ying Hu; Norma Beatriz Romero; Robert Yves Carlier; Albert Amberger; Andrea Deutschmann; Volker Straub; Marianne Rohrbach; Beat Steinmann; Kevin Rostásy; Daniela Karall; Carsten G Bönnemann; Johannes Zschocke; Christine Fauth
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

Review 7.  Extracellular matrix and heart development.

Authors:  Marie Lockhart; Elaine Wirrig; Aimee Phelps; Andy Wessels
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-25

Review 8.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

Review 9.  Golgi glycosylation and human inherited diseases.

Authors:  Hudson H Freeze; Bobby G Ng
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

Review 10.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.